Promoter methylation of BRCA1 is associated with estrogen, progesterone and human epidermal growth factor receptornegative tumors and the prognosis of breast cancer: A meta-analysis

Author：              

Publisher： Science Publishers

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.6, 2015-01, pp. : 1353-1360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis

By Wu Liang   Wang Fengliang   Xu Ruobing   Zhang Simin   Peng Xianzhen   Feng Yan   Wang Jianming   Lu Cheng  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation

By Iwamoto Takashi   Yamamoto Noriaki   Taguchi Tetsuya   Tamaki Yasuhiro   Noguchi Shinzaburo  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 69-77

Springer Publishing Company

Access to resources Recommend Favorite

A model of spontaneous mouse mammary tumor for human estrogen receptor- and progesterone receptor-negative breast cancer

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2241-2249

Spandidos Publications

Access to resources Recommend Favorite

Cancer-specific methylation in the BRCA1 promoter in sporadic breast tumours

By Ali Azhar  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 64-66

Humana Press, Inc

Access to resources Recommend Favorite

Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis

By Shi Dong-Tao   Han Mei   Gao Nan   Tian Wenyan   Chen Weichang  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 943-948

Springer Publishing Company

Access to resources Recommend Favorite